Educating Medical Professionals for that “Rare Encounter”
Streamlining the diagnostic odyssey requires educating medical professionals to recognize “rare encounters” and engage these patients with precision and compassion.
Integrated, Centralized and Decentralized Models of Digital Structure for Medical Affairs
This article provides top-level framework and broad conceptual categories for understanding digital structures within Medical Affairs and biopharmaceutical/MedTech organizations, helping leaders to make organizational decisions to drive their digital strategy with intention and purpose.
Share of Voice: Understanding How Your Research is Reaching a Real-World Audience
In this episode of the Elevate podcast series, MAPS speaks with experts about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice.
Complexities Beneath Plain Language Summaries: Challenges and Future Implications
In this webinar, we aim to gather insights from expert speakers who will cover practical lived examples of navigating the landscape, cross functional partnership for effective results, challenges that still persist, and future implications addressing the need to establish global guidelines. Perspectives from GPP guidelines, industry/patient experience, and from publishers will be the main focus.
The Digital Transformation of Medical Journal Publishing Episode 3: Open Access from the Publisher’s Perspective
In this our third episode this season, we’ll be discussing how and why medical publishing is changing and where is it going in the future.
ChatGPT is Poised to Disrupt Medical Affairs
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
Leveraging Technology and Data to Drive Expert Engagement Aligned to Strategic Imperatives
In this webinar, a panel of experts discuss how technology has aided Life Sciences leaders as they engage with experts at various stages of the product life cycle.
How Medical Affairs Can Drive Patient-Focused Drug Development
2023 brings increased expectations from the FDA for patient-focused drug development (PFDD). Medical Affairs organizations need to develop new skills to put the patient voice at the center of drug, device, and diagnostic development and evaluation.
2023, the year of personalization? Omnichannel principles for Training Strategies
This webinar highlights the continued importance of omnichannel engagement for healthcare practitioners and learners and the need to equip our internal teams appropriately.
Innovative Technologies for Smarter Pharma-Healthcare Interactions
MAPS speaks with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition, the CEOs of Discreedly and Inphronesis.